Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
Drug resistance prevents the successful treatment of HIV-positive individuals by decreasing viral sensitivity to a drug or a class of drugs. In addition to transmitted resistant viruses, treatment-naïve individuals can be confronted with the problem of drug resistance through de novo emergence of su...
Main Authors: | Thibault Mesplède, Mark A. Wainberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/7/7/2790 |
Similar Items
-
Is Resistance to Dolutegravir Possible When This Drug Is Used in First-Line Therapy?
by: Thibault Mesplède, et al.
Published: (2014-08-01) -
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study
by: José Ramón Santos, et al.
Published: (2023-06-01) -
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection
by: Alexa Vyain Zhao, et al.
Published: (2022-10-01) -
HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?
by: Vogel Martin, et al.
Published: (2009-11-01) -
Inhibition of HTLV-1 Infection by HIV-1 First- and Second-Generation Integrase Strand Transfer Inhibitors
by: Michał S. Barski, et al.
Published: (2019-08-01)